About Stemrx Bioscience Solutions Private Limited
Data last updated: 11 January 2026
Stemrx Bioscience Solutions Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 13 February 2014, the company has been in operation for over 12 years.
Registered with ROC Mumbai under CIN U93030MH2014PTC253238.
Capital: an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.28 Lakh. It is led by directors including Neetin Shivajirao Desai and Pradeep Venkatrao Mahajan.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: First Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.63 Cr, a decline of 17% compared to the previous year.
The company has a workforce of approximately 7 employees as per the latest available data.
The company is associated with 4 brands - Stemrx Biosciences, Orbisx, Stemrx Bioscience, Vrozart Health. As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stemrx.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressFirst Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited operates multiple associated brands including Stemrx Biosciences, OrbisX, and Stemrx Bioscience. These brands represent Stemrx Bioscience Solutions Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| StemRx Biosciences develops regenerative medicine and sells herbal supplements online. | stemrxbiosciences.in | |
| CRM software for automotive detailers and tinters to manage bookings, inventory, and communications. | orbisx.com | |
| Regenerative medicine and nutraceutical supplements in India. | stemrxbiosciences.com | |
| Provider of medical tourism services | vrozarthealth.com |
Competitors & Alternatives of Stemrx Bioscience Solutions Private Limited
Brands and companies operating in the same space as Stemrx Bioscience Solutions Private Limited include Kapiva, ChromaDex, Setu and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Kapiva
|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | Bengaluru, India, India | 2016 |
ChromaDex
|
Nutritional ingredients for health and wellness are developed. | Irvine, United States, United States | 1999 |
Setu
|
Dietary supplements with herbal extracts and vitamins are provided. | Mumbai, India, India | 2017 |
Mitchell International
|
SaaS-driven collision repair and auto workshop management solutions | San Diego, United States, United States | 1992 |
AutoLeap
|
SaaS-based management software is delivered for auto workshops. | Toronto, Canada, Canada | 2019 |
MotorK
|
Cloud-based digital marketing solutions are delivered for the automotive sector. | London, United Kingdom, United Kingdom | 2010 |
Shopmonkey
|
SaaS management software is delivered for auto repair workshops. | San Francisco, United States, United States | 2016 |
Rollick
|
Omnichannel marketing automation is provided to automotive OEMs and dealers. | Austin, United States, United States | 2017 |
LifeVantage
|
Nutritional products for various health ailments are provided. | Monroe, United States, United States | 2003 |
Decisiv
|
Provider cloud-based SRM solution to manage internal/external service and repair events | Richmond, United States, United States | 2001 |
Business Activity of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Auditor Details of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited is audited by MANOJ H JAISWAL for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MANOJ H JAISWAL | blur-value | blur-value | blur-value |
Board of Directors of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neetin Shivajirao Desai | Director | 13 Feb 2014 | 12 Years 4 Months | Current |
| Pradeep Venkatrao Mahajan | Director | 13 Feb 2014 | 12 Years 4 Months | Current |
| Vipula Pradeep Mahajan | Director | 13 Feb 2014 | 12 Years 4 Months | Current |
Financials of Stemrx Bioscience Solutions Private Limited FY 2025 filings available
Stemrx Bioscience Solutions Private Limited reported revenue of ₹13.63 Cr (down 17% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Stemrx Bioscience Solutions Private Limited
As of FY 2022, Stemrx Bioscience Solutions Private Limited's shareholding pattern shows 80.00% by promoters, 20.00% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Stemrx Bioscience Solutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2015 | Idbi Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited has a workforce of 7 employees as of Apr 04, 2024.
Employee Count & EPFO Data of Stemrx Bioscience Solutions Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Stemrx Bioscience Solutions Private Limited
GSTIN & GST Filing Data of Stemrx Bioscience Solutions Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Stemrx Bioscience Solutions Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Stemrx Bioscience Solutions Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Stemrx Bioscience Solutions Private Limited
MSME Payment Delays by Stemrx Bioscience Solutions Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Stemrx Bioscience Solutions Private Limited
Subsidiaries & Group Companies of Stemrx Bioscience Solutions Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Stemrx Bioscience Solutions Private Limited with ownership details.
MCA Filings & Documents of Stemrx Bioscience Solutions Private Limited
MCA Filings & Documents of Stemrx Bioscience Solutions Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Stemrx Bioscience Solutions Private Limited
Frequently Asked Questions about Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited is an active private limited company in the life sciences sector based in Navi Mumbai, Maharashtra, India. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U93030MH2014PTC253238. The company has 7 employees.
Stemrx Bioscience Solutions Private Limited reported revenue of ₹13.63 Cr for FY 2025 (down 17.00% YoY).
The current directors of Stemrx Bioscience Solutions Private Limited are:
The primary industry of Stemrx Bioscience Solutions Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes, Stemrx Bioscience Solutions Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Stemrx Bioscience Solutions Private Limited can be reached at the registered office: First Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd, Navi Mumbai, Maharashtra, India – 400708, or through the website stemrx.in.